GEMTUZUMAB OZOGAMICIN Pharmacologic Class Indexing

Class set ID
8d0cc185-a3b3-4276-af44-70180705439b
Version
3
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use MYLOTARG safely and effectively. See full prescribing information for MYLOTARG. MYLOTARG™ (gemtuzumab ozogamicin) for injection, for intravenous use Initial U.S. Approval: 2000Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pharmacia & Upjohn Company LLC | Wyeth Pharmaceutical Division of Wyeth Holdings LLC | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC2025121919